Fundación Gecp

This study tests whether adding immunotherapy to standard chemotherapy before surgery helps eliminate more tumor tissue in patients with advanced non-small cell lung cancer. About 90 participants will receive either chemo-immunotherapy or chemotherapy alone before surgery. The ma…

This study tests a treatment for people with advanced lung cancer that has spread to the brain. It combines two immunotherapy drugs (nivolumab and ipilimumab) with a short course of chemotherapy. The goal is to see if this approach can control the brain tumors for at least 6 mont…

This study looks at whether a blood test (liquid biopsy) can help doctors see how well the drug brigatinib is working in people with a specific type of advanced lung cancer (ALK-positive NSCLC). About 33 patients will take brigatinib pills and give blood samples over time. The go…

This study tests a combination of two immunotherapy drugs (pembrolizumab and lenvatinib) plus standard chemotherapy in people with extensive-stage small cell lung cancer who have not had prior treatment. The goal is to see if this triple therapy is safe and can delay cancer growt…

This study tests giving chemotherapy plus the immunotherapy drug nivolumab before surgery to people with a rare lung cancer called Pancoast tumor. The goal is to see if this combination helps shrink the tumor enough for complete removal and improves survival. About 22 adults with…